Reduction in vaso-occlusive events following stem cell transplantation in patients with sickle cell disease

Hematopoietic stem cell transplantation (HSCT) is potentially curative for patients with sickle cell disease (SCD). Patients with stable donor engraftment after allogeneic HSCT generally do not experience SCD-related complications; however, there are no published data specifically reporting the chan...

Descripción completa

Detalles Bibliográficos
Autores principales: Leonard, Alexis, Furstenau, Dana, Abraham, Allistair, Darbari, Deepika S., Nickel, Robert S., Limerick, Emily, Fitzhugh, Courtney, Hsieh, Matt, Tisdale, John F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology 2022
Materias:
Transplantation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9860452/
https://www.ncbi.nlm.nih.gov/pubmed/36240296
http://dx.doi.org/10.1182/bloodadvances.2022008137

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9860452/
https://www.ncbi.nlm.nih.gov/pubmed/36240296
http://dx.doi.org/10.1182/bloodadvances.2022008137

Ejemplares similares